Document is current
Any future updates will be listed below
-
Authors
Xu, Min https://orcid.org/0009-0001-0509-3790
Yuan, Xuanzhen https://orcid.org/0009-0008-3510-691X
Li, Peizhi https://orcid.org/0009-0003-6284-4073
Bach, Thanh
Zhu, Hao-Jie https://orcid.org/0000-0002-1931-5681
An, Guohua https://orcid.org/0000-0002-6498-7663
- License Information
-
More Information
Article History
Received: 2 August 2025
Accepted: 5 November 2025
First Online: 6 January 2026
Declarations
:
: Guohua An is a consultant of Sparrow Pharmaceuticals, Inc. Other authors in this manuscript declare no potential conflicts of interest that might be relevant to the contents of this manuscript.
